Literature DB >> 2514187

Selection and isolation of a new variant of DBA/2 mastocytoma P 815 X 2.

G Bandlow1, R Härtl.   

Abstract

A tumor model was developed in DBA/2 mice for studying the progression of the mastocytoma P 815 X 2 tumor. Tumor cells obtained from ascites were grown in vitro. The number of cells derived from a single clone was increased by in vitro culture. Cells were then injected either i.v. or i.p. into DBA/2 mice. Large volumes of tumor ascites were observed after i.p. but not i.v. injection. The latter led to tumor growth at multiple sites, especially in the liver. Mastocytoma cells were released from liver tissue and then injected i.p. into other recipients. For cloning of liver invading tumor cells, this procedure was repeated for greater than 20 generations of mice. Tumor infiltration of the liver increased strongly during this period, but ascites volume clearly decreased.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2514187     DOI: 10.1007/bf00391356

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  11 in total

1.  A transplantable mast-cell neoplasm in the mouse.

Authors:  T B DUNN; M POTTER
Journal:  J Natl Cancer Inst       Date:  1957-04       Impact factor: 13.506

2.  Isolation and metastatic properties of detachment variants of B16 melanoma cells.

Authors:  E B Briles; S Kornfeld
Journal:  J Natl Cancer Inst       Date:  1978-06       Impact factor: 13.506

3.  Selection of successive tumour lines for metastasis.

Authors:  I J Fidler
Journal:  Nat New Biol       Date:  1973-04-04

4.  Selection and altered properties of brain-colonising metastatic melanoma.

Authors:  K W Brunson; G Beattie; G L Nicolsin
Journal:  Nature       Date:  1978-04-06       Impact factor: 49.962

5.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

6.  In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties.

Authors:  G Poste; J Doll; I R Hart; I J Fidler
Journal:  Cancer Res       Date:  1980-05       Impact factor: 12.701

7.  Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between a metastasizing variant and the parental tumor line revealed by cytotoxic T lymphocytes.

Authors:  V Schirrmacher; K Bosslet; G Shantz; K Clauer; D Hübsch
Journal:  Int J Cancer       Date:  1979-02       Impact factor: 7.396

8.  Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms.

Authors:  M A Cifone; I J Fidler
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

9.  Liver-colonizing melanoma cells selected from B-16 melanoma.

Authors:  T Tao; A Matter; K Vogel; M M Burger
Journal:  Int J Cancer       Date:  1979-06-15       Impact factor: 7.396

10.  Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumour.

Authors:  I Parr
Journal:  Br J Cancer       Date:  1972-06       Impact factor: 7.640

View more
  2 in total

1.  Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking.

Authors:  A Schweiger; A Staib; B Werle; M Krasovec; T T Lah; W Ebert; V Turk; J Kos
Journal:  Br J Cancer       Date:  2000-02       Impact factor: 7.640

2.  Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients.

Authors:  B Werle; H Lötterle; U Schanzenbächer; T T Lah; E Kalman; K Kayser; H Bülzebruck; J Schirren; M Krasovec; J Kos; E Spiess
Journal:  Br J Cancer       Date:  1999-10       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.